- DocumentOMCIJ.MS.ID.555853uploaded by
Drkrishnasarma pathy
- DocumentPatent Evaluation on Monoclonal Antibody (MAB) Therapy with Binding Specificity to CD20 B-Cell Surface Antigen Bp35 and the Manufacturing Process of Biological &Antibodies and Derivativesuploaded by
Drkrishnasarma pathy
- DocumentInternational Journal of Research Studies in Medical and Health Sciences-Antiviral nucleosides- Flu Viruses- QUINOLINES-COVID-19 Dr Krishna sarma pathyuploaded by
Drkrishnasarma pathy
- DocumentHCV NS3/4A 3 Protease Inhibitorsuploaded by
Drkrishnasarma pathy
- DocumentBJSTR.MS.ID.003667 Chronic Hepatitis (Chc), Viral Polymerase Nucleotide Inhibitor & Process Patents Review and Evaluation, Preparation of Sofosbuviruploaded by
Drkrishnasarma pathy
- DocumentLOJMS.MS.ID.000121 An anti-inflammatory adrenocorticalsteroid Hydrocortisonesodiumsuccinate, hydrocortisone preparation and validated for the confirmation/ determination and quantification of hydrocortisoneuploaded by
Drkrishnasarma pathy
- DocumentAn Anti-Inflammatory Adrenocorticalsteroid Hydrocortisonesodiumsuccinate, Hydrocortisone Preparation and Validated for the Confirmation Determination and Quantification of Hydrocortisoneuploaded by
Drkrishnasarma pathy
- Documentlojuploaded by
Drkrishnasarma pathy
- Documentconsiderationsuploaded by
Drkrishnasarma pathy
- Documentcefpodoximeuploaded by
Drkrishnasarma pathy
- Documentlojuploaded by
Drkrishnasarma pathy
- Documentbjstr.ms.id.001662considerationsuploaded by
Drkrishnasarma pathy
- Documentconsiderationsuploaded by
Drkrishnasarma pathy
- Documentbjstr.ms.id.001662considerationsuploaded by
Drkrishnasarma pathy
- DocumentJOJS.MS.ID.555566 (1)Case History-The Control of Impurities-A Critical Issue to The Active Pharmaceutical Ingredientuploaded by
Drkrishnasarma pathy
- DocumentCase History-The Control of Impurities-A Critical Issue to The Active Pharmaceutical Ingredient JOJ Scin 1(4) JOJS.ms.ID.555566 (2018) Krishnasarmapathyuploaded by
Drkrishnasarma pathy
- DocumentKrishnasarma Pathy K (2018) Entecavir Patent Evaluation & Genotoxicityuploaded by
Drkrishnasarma pathy
- DocumentHerald Scholarly Open AccessPathy K (2018) Entecavir Patent Evaluation & Genotoxicity. J Toxicol Cur Res 2 005.uploaded by
Drkrishnasarma pathy
- DocumentKrishnasarma Pathy K (2018) Entecavir Patent Evaluation & Genotoxicityuploaded by
Drkrishnasarma pathy
- DocumentJPP-18-RA-1899-Entecavir-patent-evaluation--method--for-diastereomeric-Impurities--/1899uploaded by
Drkrishnasarma pathy
- DocumentHttpswww.ommegaonline.orgarticle Details Entecavir Patent Evaluation Method for Diastereomeric Impurities 1899uploaded by
Drkrishnasarma pathy
- DocumentEntecavir Patent Evaluation, Method for Diastereomeric Impurities OMCIJ.MS.ID.555711uploaded by
Drkrishnasarma pathy
- DocumentPreparation of Vitamin C and Method for Determination of Vitamin C in Tablets SCSOAJ.ms.ID.000114uploaded by
Drkrishnasarma pathy
- DocumentRoute Evaluation and Analytical HPLC Method Development of Buprenorphine, Naloxone, And Comparison OverallSJFN.ms.ID.000105uploaded by
Drkrishnasarma pathy
- DocumentOMCIJ.MS.ID.555674 .uploaded by
Drkrishnasarma pathy
- DocumentSRMRCR-01-00014 (1)uploaded by
Drkrishnasarma pathy
- DocumentOAJT.ms.ID.555593 Krishnasarmapathyuploaded by
Drkrishnasarma pathy
- DocumentOAJT.ms.ID.555592krishnasarmapathyuploaded by
Drkrishnasarma pathy
- DocumentInt J clinical & case. 1:7, 140-144-The influenza A virus subtypes H1N1, H1N2 and H3N2 ,HDFxuploaded by
Drkrishnasarma pathy
- DocumentThe influenza A virus subtypes H1N1, H1N2 and H3N2 ,HDFxuploaded by
Drkrishnasarma pathy
- DocumentOAJT.MS.ID.555568 (1)Research Article Volume 1 Issue 4 - August 2017 DOIuploaded by
Drkrishnasarma pathy
- DocumentOAJT.MS.ID.555568 (1)uploaded by
Drkrishnasarma pathy
- DocumentMethod Development and Pharmacological study of Chemotherapeutic Agents OAJT.ms.ID.555568 Drkrishnasarmapathyuploaded by
Drkrishnasarma pathy
- DocumentBASIC SKILLS TRAINING GUIDE -HPLC method development and validation- an overview Dr Sarma Krishna pathy ,YLN Murthy,Sunithasarma,Atchuutha ramaiahuploaded by
Drkrishnasarma pathy
- DocumentBASIC SKILLS TRAINING GUIDE -HPLC Method Development and Validation- An Overview-1uploaded by
Drkrishnasarma pathy
- DocumentS- Amlo Besylateuploaded by
Drkrishnasarma pathy
- DocumentIndustrial process for OXICONAZOLE Dr krishnasarma Pathy step-I 2,2’4’-tri-choloroacetophenone,Imidazole reacted in presence of acetonitrile to form 1-(2,4-dichlorophenacyl)-imidazole (I).Which is then reacted with hydroxylamine. hydrochloride to give (Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl) ethanone oxime (II). It is further reacted with 2,4-Dichlorobenzyl chloride in presence of sodium hydride to give (III) Oxiconazole and finally salt formation with nitric aciduploaded by
Drkrishnasarma pathy
- DocumentArticleuploaded by
Drkrishnasarma pathy
- DocumentLab Notebook Example-Tris[(2-pyridyl)methyl]amineuploaded by
Drkrishnasarma pathy
- DocumentIPR - A Primer on Intellectual Property Rights-Dr KrishnasarmaPathyuploaded by
Drkrishnasarma pathy
- DocumentSolid-state Forms of Celecoxib and an Improved Process for the Preparation of Celecoxib Polymorphuploaded by
Drkrishnasarma pathy
- DocumentCELECOXIBuploaded by
Drkrishnasarma pathy
- DocumentIndustrial process for preparation of Levetiracetam.uploaded by
Drkrishnasarma pathy
- DocumentLevi Trace Tamuploaded by
Drkrishnasarma pathy
- DocumentIndustrial process for preparation of Levetiracetam.uploaded by
Drkrishnasarma pathy
- DocumentLevi Trace Tamuploaded by
Drkrishnasarma pathy
- DocumentVITAMIN Cuploaded by
Drkrishnasarma pathy
- DocumentPHENYLEPHRINEuploaded by
Drkrishnasarma pathy
- DocumentDEFINITION “IMPURITY”uploaded by
Drkrishnasarma pathy